New injection study aims to ease uncontrollable eye blinking
NCT ID NCT07489430
First seen May 05, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This study looks at how well and how long DaxibotulinumtoxinA (DAXI) works for adults with blepharospasm, a condition causing uncontrollable blinking or eye muscle spasms. Twenty participants will receive up to three injection cycles over a year. The goal is to measure the time between treatments and track symptom relief and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEPHAROSPASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Parkinson Disease and Movement Disorders Center at the University of Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.